Nestlé to buy Pfizer’s infant-nutrition business
Swiss food and drink giant Nestlé has announced a deal to acquire Pfizer’s infant-nutrition business for $11.85 billion (SFr10.8 billion).
The Vevey-based company says the acquisition, subject to regulatory approval, would “enhance its position in global infant nutrition”.
Nestlé CEO Paul Bulcke called the deal to buy the Pfizer nutrition unit “an excellent strategic fit”.
Nestlé said in a statement on Monday that estimated sales from the acquired business would be $2.4 billion in 2012.
It said 85 per cent of those sales are in emerging markets, many of which have large, fast-growing populations.
Nestlé is one of the world’s largest sellers of infant formula and may face some antitrust hurdles to complete the deal.
More
No house generation: the impossibility of buying property in Switzerland
More
Online quarrel reveals Swiss life of luxury of Cameroon’s ruling family
More
UK and Switzerland open way for direct rail link
More
Cross purposes: the unique Swiss flag
More
Activist takes on Swatch maverick as Omega empire falters
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.